(TMV) TeamViewer - Ratings and Ratios
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE000A2YN900
Remote Access, Enterprise Connectivity, Digital Workflows, Augmented Reality
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 46.1% |
| Value at Risk 5%th | 59.0% |
| Relative Tail Risk | -22.31% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.34 |
| Alpha | -54.98 |
| CAGR/Max DD | -0.40 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.415 |
| Beta | 0.231 |
| Beta Downside | 0.131 |
| Drawdowns 3y | |
|---|---|
| Max DD | 68.99% |
| Mean DD | 29.12% |
| Median DD | 28.84% |
Description: TMV TeamViewer January 16, 2026
TeamViewer SE (XETRA:TMV) delivers a portfolio of remote-connectivity software, including TeamViewer Remote (access and control), Tensor (enterprise-grade IT and device management), Frontline (digital workflow assistance for field workers), and Dex (real-time diagnostics with AI-driven automation). The suite is complemented by AR/MR tools for logistics, manufacturing, and after-sales processes, positioning the firm as a one-stop shop for remote operation and support across industrial and enterprise environments.
Key metrics (FY 2023): revenue of €1.02 bn, year-over-year ARR growth of ~30 % and a net-revenue retention rate of 112 %, indicating strong upsell potential. The remote-work software market is expanding at a 12-% CAGR, driven by continued digital transformation and the rise of hybrid work models, while the industrial IoT segment-TeamViewer’s target for Tensor and Dex-is projected to reach €150 bn by 2027. However, churn remains a material risk, with the latest disclosed churn rate around 5 % for enterprise contracts.
For a deeper, data-rich assessment of TMV’s valuation dynamics, you may find it worthwhile to explore the analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 115.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA -8.15 > 1.0 |
| NWC/Revenue: -105.3% < 20% (prev -67.85%; Δ -37.40% < -1%) |
| CFO/TA 0.13 > 3% & CFO 217.1m > Net Income 115.6m |
| Net Debt (969.6m) to EBITDA (254.8m): 3.81 < 3 |
| Current Ratio: 0.12 > 1.5 & < 3 |
| Outstanding Shares: last quarter (158.0m) vs 12m ago -0.26% < -2% |
| Gross Margin: 87.38% > 18% (prev 0.87%; Δ 8651 % > 0.5%) |
| Asset Turnover: 54.34% > 50% (prev 64.32%; Δ -9.98% > 0%) |
| Interest Coverage Ratio: 6.11 > 6 (EBITDA TTM 254.8m / Interest Expense TTM 33.6m) |
Altman Z'' (< 1.1 .. > 2.6) -1.63
| A: -0.46 (Total Current Assets 107.2m - Total Current Liabilities 876.4m) / Total Assets 1.67b |
| B: 0.07 (Retained Earnings 108.8m / Total Assets 1.67b) |
| C: 0.15 (EBIT TTM 205.5m / Avg Total Assets 1.34b) |
| D: 0.15 (Book Value of Equity 227.9m / Total Liabilities 1.54b) |
| Total Rating: -1.63= D |
ValueRay F-Score (Strict, 0-100) 80.22
| 1. Piotroski: 5.50pt |
| 2. FCF Yield: 11.26% |
| 3. FCF Margin: 28.84% |
| 4. Debt/Equity: 7.60 |
| 5. Debt/Ebitda: 3.81 |
| 6. ROIC - WACC: 31.09% |
| 7. RoE: 108.1% |
| 8. Revenue Trend: 99.11% |
| 9. EPS Trend: 1.03% |
What is the price of TMV shares?
As of January 22, 2026, the stock is trading at EUR 5.57 with a total of 1,096,120 shares traded.
Over the past week, the price has changed by -7.48%, over one month by -6.31%, over three months by -34.32% and over the past year by -47.65%.
Over the past week, the price has changed by -7.48%, over one month by -6.31%, over three months by -34.32% and over the past year by -47.65%.
Is TMV a buy, sell or hold?
TeamViewer has no consensus analysts rating.
What are the forecasts/targets for the TMV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 10.5 | 87.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 4.3 | -23% |
TMV Fundamental Data Overview January 20, 2026
Market Cap USD = 1.05b (901.8m EUR * 1.1673 EUR.USD)
P/E Trailing = 7.8699
P/E Forward = 4.8286
P/S = 1.2339
P/B = 6.8748
P/EG = 0.3095
Revenue TTM = 730.8m EUR
EBIT TTM = 205.5m EUR
EBITDA TTM = 254.8m EUR
Long Term Debt = 537.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 460.1m EUR (from shortTermDebt, last quarter)
Debt = 997.5m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 969.6m EUR (from netDebt column, last quarter)
Enterprise Value = 1.87b EUR (901.8m + Debt 997.5m - CCE 27.9m)
Interest Coverage Ratio = 6.11 (Ebit TTM 205.5m / Interest Expense TTM 33.6m)
EV/FCF = 8.88x (Enterprise Value 1.87b / FCF TTM 210.8m)
FCF Yield = 11.26% (FCF TTM 210.8m / Enterprise Value 1.87b)
FCF Margin = 28.84% (FCF TTM 210.8m / Revenue TTM 730.8m)
Net Margin = 15.82% (Net Income TTM 115.6m / Revenue TTM 730.8m)
Gross Margin = 87.38% ((Revenue TTM 730.8m - Cost of Revenue TTM 92.2m) / Revenue TTM)
Gross Margin QoQ = 86.75% (prev 86.70%)
Tobins Q-Ratio = 1.12 (Enterprise Value 1.87b / Total Assets 1.67b)
Interest Expense / Debt = 1.04% (Interest Expense 10.4m / Debt 997.5m)
Taxrate = 26.94% (10.6m / 39.2m)
NOPAT = 150.2m (EBIT 205.5m * (1 - 26.94%))
Current Ratio = 0.12 (Total Current Assets 107.2m / Total Current Liabilities 876.4m)
Debt / Equity = 7.60 (Debt 997.5m / totalStockholderEquity, last quarter 131.2m)
Debt / EBITDA = 3.81 (Net Debt 969.6m / EBITDA 254.8m)
Debt / FCF = 4.60 (Net Debt 969.6m / FCF TTM 210.8m)
Total Stockholder Equity = 106.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.60% (Net Income 115.6m / Total Assets 1.67b)
RoE = 108.1% (Net Income TTM 115.6m / Total Stockholder Equity 106.9m)
RoCE = 31.90% (EBIT 205.5m / Capital Employed (Equity 106.9m + L.T.Debt 537.4m))
RoIC = 34.71% (NOPAT 150.2m / Invested Capital 432.6m)
WACC = 3.62% (E(901.8m)/V(1.90b) * Re(6.77%) + D(997.5m)/V(1.90b) * Rd(1.04%) * (1-Tc(0.27)))
Discount Rate = 6.77% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.34%
[DCF Debug] Terminal Value 86.88% ; FCFF base≈211.4m ; Y1≈223.6m ; Y5≈264.9m
Fair Price DCF = 43.85 (EV 7.85b - Net Debt 969.6m = Equity 6.88b / Shares 157.0m; r=5.90% [WACC]; 5y FCF grow 6.35% → 2.90% )
EPS Correlation: 1.03 | EPS CAGR: -31.72% | SUE: -2.34 | # QB: 0
Revenue Correlation: 99.11 | Revenue CAGR: 10.06% | SUE: -0.88 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.20 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=1.11 | Chg30d=+0.013 | Revisions Net=-1 | Growth EPS=+8.5% | Growth Revenue=+3.8%
P/E Trailing = 7.8699
P/E Forward = 4.8286
P/S = 1.2339
P/B = 6.8748
P/EG = 0.3095
Revenue TTM = 730.8m EUR
EBIT TTM = 205.5m EUR
EBITDA TTM = 254.8m EUR
Long Term Debt = 537.4m EUR (from longTermDebt, last quarter)
Short Term Debt = 460.1m EUR (from shortTermDebt, last quarter)
Debt = 997.5m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 969.6m EUR (from netDebt column, last quarter)
Enterprise Value = 1.87b EUR (901.8m + Debt 997.5m - CCE 27.9m)
Interest Coverage Ratio = 6.11 (Ebit TTM 205.5m / Interest Expense TTM 33.6m)
EV/FCF = 8.88x (Enterprise Value 1.87b / FCF TTM 210.8m)
FCF Yield = 11.26% (FCF TTM 210.8m / Enterprise Value 1.87b)
FCF Margin = 28.84% (FCF TTM 210.8m / Revenue TTM 730.8m)
Net Margin = 15.82% (Net Income TTM 115.6m / Revenue TTM 730.8m)
Gross Margin = 87.38% ((Revenue TTM 730.8m - Cost of Revenue TTM 92.2m) / Revenue TTM)
Gross Margin QoQ = 86.75% (prev 86.70%)
Tobins Q-Ratio = 1.12 (Enterprise Value 1.87b / Total Assets 1.67b)
Interest Expense / Debt = 1.04% (Interest Expense 10.4m / Debt 997.5m)
Taxrate = 26.94% (10.6m / 39.2m)
NOPAT = 150.2m (EBIT 205.5m * (1 - 26.94%))
Current Ratio = 0.12 (Total Current Assets 107.2m / Total Current Liabilities 876.4m)
Debt / Equity = 7.60 (Debt 997.5m / totalStockholderEquity, last quarter 131.2m)
Debt / EBITDA = 3.81 (Net Debt 969.6m / EBITDA 254.8m)
Debt / FCF = 4.60 (Net Debt 969.6m / FCF TTM 210.8m)
Total Stockholder Equity = 106.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.60% (Net Income 115.6m / Total Assets 1.67b)
RoE = 108.1% (Net Income TTM 115.6m / Total Stockholder Equity 106.9m)
RoCE = 31.90% (EBIT 205.5m / Capital Employed (Equity 106.9m + L.T.Debt 537.4m))
RoIC = 34.71% (NOPAT 150.2m / Invested Capital 432.6m)
WACC = 3.62% (E(901.8m)/V(1.90b) * Re(6.77%) + D(997.5m)/V(1.90b) * Rd(1.04%) * (1-Tc(0.27)))
Discount Rate = 6.77% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.34%
[DCF Debug] Terminal Value 86.88% ; FCFF base≈211.4m ; Y1≈223.6m ; Y5≈264.9m
Fair Price DCF = 43.85 (EV 7.85b - Net Debt 969.6m = Equity 6.88b / Shares 157.0m; r=5.90% [WACC]; 5y FCF grow 6.35% → 2.90% )
EPS Correlation: 1.03 | EPS CAGR: -31.72% | SUE: -2.34 | # QB: 0
Revenue Correlation: 99.11 | Revenue CAGR: 10.06% | SUE: -0.88 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.20 | Chg30d=N/A | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=1.11 | Chg30d=+0.013 | Revisions Net=-1 | Growth EPS=+8.5% | Growth Revenue=+3.8%